rs200303340
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM1PP2PP3
The NM_000257.4(MYH7):βc.5243G>Aβ(p.Cys1748Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000396 in 1,614,124 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000257.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYH7 | NM_000257.4 | c.5243G>A | p.Cys1748Tyr | missense_variant | Exon 36 of 40 | ENST00000355349.4 | NP_000248.2 | |
MYH7 | NM_001407004.1 | c.5243G>A | p.Cys1748Tyr | missense_variant | Exon 35 of 39 | NP_001393933.1 | ||
MHRT | NR_126491.1 | n.-29C>T | upstream_gene_variant |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152230Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000477 AC: 12AN: 251482Hom.: 0 AF XY: 0.0000662 AC XY: 9AN XY: 135918
GnomAD4 exome AF: 0.0000383 AC: 56AN: 1461894Hom.: 0 Cov.: 34 AF XY: 0.0000413 AC XY: 30AN XY: 727248
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152230Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74368
ClinVar
Submissions by phenotype
Cardiomyopathy Uncertain:2
This missense variant replaces cysteine with tyrosine at codon 1748 of the MYH7 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with hypertrophic cardiomyopathy (PMID: 34598319). It has also been reported in an individual affected with long QT syndrome and sudden cardiac arrest (PMID: 30403391). This variant has been identified in 14/282884 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
This missense variant replaces cysteine with tyrosine at codon 1748 of the MYH7 protein. Computational prediction tools indicate that this variant has a neutral impact on protein structure and function. To our knowledge, functional studies have not been reported for this variant. This variant has been reported in one individual affected with hypertrophic cardiomyopathy (PMID: 34598319). It has also been reported in one individual affected with long QT syndrome and sudden cardiac arrest (PMID: 30403391). This variant has been identified in 14/282884 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
not provided Uncertain:2
A variant of uncertain significance has been identified in the MYH7 gene. The C1748Y variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The C1748Y variant is observed in 6/66738 (0.01%) alleles from individuals of non-Finnish European background, (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The C1748Y variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. Based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. -
- -
Primary familial hypertrophic cardiomyopathy Pathogenic:1
- -
Dilated cardiomyopathy 1S;C1842160:Myosin storage myopathy;C1850709:Myopathy, myosin storage, autosomal recessive;C3495498:Hypertrophic cardiomyopathy 1;C4552004:MYH7-related skeletal myopathy Uncertain:1
MYH7 NM_00257.3 exon 36 p.Cys1748Tyr (c.5243G>A): This variant has not been reported in the literature and is present in 0.009% (12/129192) of European alleles in the Genome Aggregation Database (http://gnomad.broadinstitute.org/variant/14-23884630-C-T). This variant is present in ClinVar (Variation ID:180440). Evolutionary conservation and computational predictive tools suggest that this variant may impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. -
Dilated cardiomyopathy 1S Uncertain:1
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
Myosin storage myopathy Uncertain:1
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
Hypertrophic cardiomyopathy Uncertain:1
This sequence change replaces cysteine, which is neutral and slightly polar, with tyrosine, which is neutral and polar, at codon 1748 of the MYH7 protein (p.Cys1748Tyr). This variant is present in population databases (rs200303340, gnomAD 0.009%). This missense change has been observed in individual(s) with hypertrophic cardiomyopathy (PMID: 34598319, 37652022). ClinVar contains an entry for this variant (Variation ID: 180440). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on MYH7 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
MYH7-related disorder Uncertain:1
The MYH7 c.5243G>A variant is predicted to result in the amino acid substitution p.Cys1748Tyr. This variant has been reported as a variant of uncertain significance in individuals with long QT syndrome and sudden cardiac arrest (Table S6, StΔpieΕ-Wojno et al. 2018. PubMed ID: 30403391) and hypertrophic cardiomyopathy (Filatova et al. 2021. PubMed ID: 34598319). This variant was also documented in both control and affected individuals in a population-based study estimating the penetrance of rare variants in cardiomyopathy-associated genes (Table S8, McGurk et al. 2023. PubMed ID: 37652022). This variant is reported in 0.0093% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Cardiovascular phenotype Uncertain:1
The p.C1748Y variant (also known as c.5243G>A), located in coding exon 34 of the MYH7 gene, results from a G to A substitution at nucleotide position 5243. The cysteine at codon 1748 is replaced by tyrosine, an amino acid with highly dissimilar properties. This variant was reported in individual(s) with features consistent with hypertrophic cardiomyopathy (Filatova EV et al. Mol Genet Genomic Med, 2021 11;9:e1808; McGurk KA et al. Am J Hum Genet. 2023 Sep;110(9):1482-1495). This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear. -
Hypertrophic cardiomyopathy 1 Uncertain:1
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
MYH7-related skeletal myopathy Benign:1
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at